Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
FDA Orange Book
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta Subunit Hcg (123-145)
2. Hcg-beta (123-145)
1. Hcg-beta (123-145)
2. Beta-subunit Hcg (123-145)
3. 66053-67-6
4. Beta Subunit Hcg (123-145)
5. L-glutamine, L-alanyl-l-prolyl-l-prolyl-l-prolyl-l-seryl-l-leucyl-l-prolyl-l-seryl-l-prolyl-l-seryl-l-arginyl-l-leucyl-l-prolylglycyl-l-prolyl-l-seryl-l-alpha-aspartyl-l-threonyl-l-prolyl-l-isoleucyl-l-leucyl-l-prolyl-
Molecular Weight | 2321.6 g/mol |
---|---|
Molecular Formula | C105H169N27O32 |
XLogP3 | -8.6 |
Hydrogen Bond Donor Count | 25 |
Hydrogen Bond Acceptor Count | 34 |
Rotatable Bond Count | 59 |
Exact Mass | 2321.2460512 g/mol |
Monoisotopic Mass | 2320.2426963 g/mol |
Topological Polar Surface Area | 868 Ų |
Heavy Atom Count | 164 |
Formal Charge | 0 |
Complexity | 5430 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 24 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Human Chorionic Gonadotropin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier.
PharmaCompass also assists you with knowing the Human Chorionic Gonadotropin API Price utilized in the formulation of products. Human Chorionic Gonadotropin API Price is not always fixed or binding as the Human Chorionic Gonadotropin Price is obtained through a variety of data sources. The Human Chorionic Gonadotropin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hcg-Beta 123-145 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hcg-Beta 123-145, including repackagers and relabelers. The FDA regulates Hcg-Beta 123-145 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hcg-Beta 123-145 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hcg-Beta 123-145 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hcg-Beta 123-145 supplier is an individual or a company that provides Hcg-Beta 123-145 active pharmaceutical ingredient (API) or Hcg-Beta 123-145 finished formulations upon request. The Hcg-Beta 123-145 suppliers may include Hcg-Beta 123-145 API manufacturers, exporters, distributors and traders.
click here to find a list of Hcg-Beta 123-145 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hcg-Beta 123-145 DMF (Drug Master File) is a document detailing the whole manufacturing process of Hcg-Beta 123-145 active pharmaceutical ingredient (API) in detail. Different forms of Hcg-Beta 123-145 DMFs exist exist since differing nations have different regulations, such as Hcg-Beta 123-145 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hcg-Beta 123-145 DMF submitted to regulatory agencies in the US is known as a USDMF. Hcg-Beta 123-145 USDMF includes data on Hcg-Beta 123-145's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hcg-Beta 123-145 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hcg-Beta 123-145 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hcg-Beta 123-145 Drug Master File in Japan (Hcg-Beta 123-145 JDMF) empowers Hcg-Beta 123-145 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hcg-Beta 123-145 JDMF during the approval evaluation for pharmaceutical products. At the time of Hcg-Beta 123-145 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hcg-Beta 123-145 suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hcg-Beta 123-145 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hcg-Beta 123-145 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hcg-Beta 123-145 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hcg-Beta 123-145 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hcg-Beta 123-145 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hcg-Beta 123-145 suppliers with NDC on PharmaCompass.
Hcg-Beta 123-145 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hcg-Beta 123-145 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hcg-Beta 123-145 GMP manufacturer or Hcg-Beta 123-145 GMP API supplier for your needs.
A Hcg-Beta 123-145 CoA (Certificate of Analysis) is a formal document that attests to Hcg-Beta 123-145's compliance with Hcg-Beta 123-145 specifications and serves as a tool for batch-level quality control.
Hcg-Beta 123-145 CoA mostly includes findings from lab analyses of a specific batch. For each Hcg-Beta 123-145 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hcg-Beta 123-145 may be tested according to a variety of international standards, such as European Pharmacopoeia (Hcg-Beta 123-145 EP), Hcg-Beta 123-145 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hcg-Beta 123-145 USP).